Proceedings (Aug 2019)
Dibenzylxanthines as PPEPCK-M Inhibitors for Cancer Therapy
Abstract
Phosphoenolpyruvate carboxykinase (PEPCK) is the key enzyme in gluconeogenesis/glyceroneogenesis, which catalyzes the decarboxylation of oxaloacetate to phosphoenolpyruvate. [...]
Keywords